SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001346302-18-000016
Filing Date
2018-08-14
Accepted
2018-08-13 18:34:22
Documents
53
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q q22018form10-q.htm 10-Q 1122103
2 EXHIBIT 31.1 q22018exhibit311.htm EX-31.1 13587
3 EXHIBIT 31.2 q22018exhibit312.htm EX-31.2 13663
4 EXHIBIT 32.1 q22018exhibit321.htm EX-32.1 10449
  Complete submission text file 0001346302-18-000016.txt   3452697

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT xers-20180630.xml EX-101.INS 438836
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20180630.xsd EX-101.SCH 32785
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20180630_cal.xml EX-101.CAL 26072
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20180630_def.xml EX-101.DEF 120814
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20180630_lab.xml EX-101.LAB 340711
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20180630_pre.xml EX-101.PRE 196744
Mailing Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601 512-498-2670
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38536 | Film No.: 181013729
SIC: 2834 Pharmaceutical Preparations